Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Current Drug Metabolism|May 11, 2010
Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approachesMahmud Tareq Hassan KhanNew Biotechnology|June 4, 2009
Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospectsMahmud Tareq Hassan KhanIn Silico Biology|October 3, 2009
Determinants for psychrophilic and thermophilic features of metallopeptidases of the M4 familyMahmud Tareq Hassan Khan, Ingebrigt SylteBiotechnology Annual Review|July 9, 2008
Ethnomedicines and ethnomedicinal phytophores against herpesvirusesDebprasad Chattopadhyay, Mahmud Tareq Hassan KhanCurrent Drug Discovery Technologies|November 8, 2007
Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug moleculesMahmud Tareq Hassan Khan, Ingebrigt SylteBiotechnology Annual Review|September 19, 2007
Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agentsMahmud Tareq Hassan Khan, Arjumand AtherCurrent Topics in Medicinal Chemistry|May 24, 2014
Flavonoid derivatives as potent tyrosinase inhibitors - a survey of recent findings between 2008-2013Ilkay Erdogan Orhan, Mahmud Tareq Hassan KhanBioorganic & Medicinal Chemistry|October 6, 2005
Tyrosinase inhibitory cycloartane type triterpenoids from the methanol extract of the whole plant of Amberboa ramosa Jafri and their structure-activity relationshipMahmud Tareq Hassan Khan, Sher Bahadar Khan, Arjumand AtherJournal of Medicinal Chemistry|December 17, 2008
Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assaysMahmud Tareq Hassan Khan, Ole-Martin Fuskevåg, Ingebrigt SylteCellular and Molecular Life Sciences : CMLS|July 20, 2010
The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitorSergiy Kostenko, Mahmud Tareq Hassan Khan, Ingebrigt Sylte, et al.Pageof 6